Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Characterization of a novel ATP-sensitive K+ channel opener, A-251179, on urinary bladder relaxation and cystometric parameters.

Shieh CC, Brune ME, Buckner SA, Whiteaker KL, Molinari EJ, Milicic IA, Fabiyi AC, Daza A, Brioni JD, Carroll WA, Matsushita K, Yamada M, Kurachi Y, Gopalakrishnan M.

Br J Pharmacol. 2007 Jun;151(4):467-75. Epub 2007 Apr 16.

2.

[125I]A-312110, a novel high-affinity 1,4-dihydropyridine ATP-sensitive K+ channel opener: characterization and pharmacology of binding.

Davis-Taber R, Molinari EJ, Altenbach RJ, Whiteaker KL, Shieh CC, Rotert G, Buckner SA, Malysz J, Milicic I, McDermott JS, Gintant GA, Coghlan MJ, Carroll WA, Scott VE, Gopalakrishnan M.

Mol Pharmacol. 2003 Jul;64(1):143-53.

PMID:
12815170
3.

Pharmacological characterization of a 1,4-dihydropyridine analogue, 9-(3,4-dichlorophenyl)-3,3,6,6-tetramethyl-3,4,6,7,9,10-hexahydro-1,8(2H,5H)-acridinedione (A-184209) as a novelK(ATP) channel inhibitor.

Gopalakrishnan M, Miller TR, Buckner SA, Milicic I, Molinari EJ, Whiteaker KL, Davis-Taber R, Scott VE, Cassidy C, Sullivan JP, Carroll WA.

Br J Pharmacol. 2003 Jan;138(2):393-9.

4.

(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. I. In vitro characterization.

Gopalakrishnan M, Buckner SA, Whiteaker KL, Shieh CC, Molinari EJ, Milicic I, Daza AV, Davis-Taber R, Scott VE, Sellers D, Chess-Williams R, Chapple CR, Liu Y, Liu D, Brioni JD, Sullivan JP, Williams M, Carroll WA, Coghlan MJ.

J Pharmacol Exp Ther. 2002 Oct;303(1):379-86.

PMID:
12235274
5.

Expression of cloned receptors in mammalian cell lines.

Gopalakrishnan M, Molinari EJ.

Curr Protoc Pharmacol. 2001 May;Chapter 6:Unit6.3. doi: 10.1002/0471141755.ph0603s00. No abstract available.

PMID:
21971812
6.

Pharmacology of human sulphonylurea receptor SUR1 and inward rectifier K(+) channel Kir6.2 combination expressed in HEK-293 cells.

Gopalakrishnan M, Molinari EJ, Shieh CC, Monteggia LM, Roch JM, Whiteaker KL, Scott VE, Sullivan JP, Brioni JD.

Br J Pharmacol. 2000 Apr;129(7):1323-32.

7.

Characterization and modulation of [125I]iberiotoxin-D19Y/Y36F binding in the guinea-pig urinary bladder.

Molinari EJ, Sullivan JP, Wan Y, Brioni JD, Gopalakrishnan M.

Eur J Pharmacol. 2000 Jan 28;388(2):155-61.

PMID:
10666507
8.

Pharmacological and molecular characterization of ATP-sensitive K+ channels in the TE671 human medulloblastoma cell line.

Miller TR, Taber RD, Molinari EJ, Whiteaker KL, Monteggia LM, Scott VE, Brioni JD, Sullivan JP, Gopalakrishnan M.

Eur J Pharmacol. 1999 Apr 9;370(2):179-85. Review.

PMID:
10323267
9.

Characterization of the ATP-sensitive potassium channels (KATP) expressed in guinea pig bladder smooth muscle cells.

Gopalakrishnan M, Whiteaker KL, Molinari EJ, Davis-Taber R, Scott VE, Shieh CC, Buckner SA, Milicic I, Cain JC, Postl S, Sullivan JP, Brioni JD.

J Pharmacol Exp Ther. 1999 Apr;289(1):551-8.

PMID:
10087049
10.

Up-regulation of human alpha7 nicotinic receptors by chronic treatment with activator and antagonist ligands.

Molinari EJ, Delbono O, Messi ML, Renganathan M, Arneric SP, Sullivan JP, Gopalakrishnan M.

Eur J Pharmacol. 1998 Apr 17;347(1):131-9.

PMID:
9650859
11.
12.

The high affinity melationin binding site probed with conformationally restricted ligand--I. Pharmacophore and minireceptor models.

Jansen JM, Copinga S, Gruppen G, Molinari EJ, Dubocovich ML, Grol CJ.

Bioorg Med Chem. 1996 Aug;4(8):1321-32.

PMID:
8879554
13.
14.

Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor.

Gopalakrishnan M, Monteggia LM, Anderson DJ, Molinari EJ, Piattoni-Kaplan M, Donnelly-Roberts D, Arneric SP, Sullivan JP.

J Pharmacol Exp Ther. 1996 Jan;276(1):289-97.

PMID:
8558445

Supplemental Content

Loading ...
Support Center